Status:
UNKNOWN
Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Conditions:
Coenzyme Q10 on Athero-thrombosis in APS Patients
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study will be performed on 50 APS (antiphospholipid Syndrome) patients, which will be randomized to receive either CoQ10 (200mg/day) or placebo for one month. Blood will be drawn at time 0 and at ...
Eligibility Criteria
Inclusion
- Patients who fulfilled Sidney criteria for APS (antiphospholipid Syndrome) (Miyakis S et al., J Thromb Haemost 2006; 4:295-306)
- Age over 18 years
- Written informed consent
Exclusion
- Acute Liver Disease.
- Severe renal impairment
- Acute arterial or venous thrombosis episode in the last 3 months
- Pregnancy and breastfeeding
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02218476
Start Date
September 1 2013
Last Update
August 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Reina Sofía de Córdoba
Córdoba, Andalusia, Spain, 14004